金沙娱城手机app下载

Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX01
CD20-Positive B-cell Lymphomas
Phase 1a

A Phase 1a Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients with CD20-positive B-cell Lymphomas

HLX01
CD20-positive B-cell Lymphomas
Phase 1

A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 and Rituximab

HLX01
DLBCL
Phase 3

Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

HLX01
RA
Phase 1/2

A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

HLX01
RA
Phase 3

A Phase 3 Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis

Baidu
sogou